Aker BioMarine ASA Overview
Pro stress-test →Aker BioMarine is a Norway-based biotech innovator and Antarctic krill-harvesting company with a vertically integrated supply chain spanning harvesting in Antarctica through manufacturing and distribution. The company develops and supplies krill-derived products for consumer health and wellness worldwide, capturing value across multiple market segments from B2B ingredients to consumer brands.
Strategic Profile
Pro stress-test →The company is a supplier of krill-derived products with a fully owned supply chain, with operations spanning from harvesting krill in Antarctica with owned vessels including distribution from Uruguay, and processing of krill into oil products in the United States. Category-defining product launches and deep R&D investment position the company for premium pricing and margin expansion, with sustainability leadership supporting market share gains in global health and nutrition markets.
Competitive Landscape
Pro stress-test →The company faces limited direct competition, with Rochem International identified as a competitor in the krill-derivatives space. Broader competition comes from omega-3 supplement providers and traditional fish oil manufacturers. Aker BioMarine's sustainability credentials, vertical integration, and Antarctic harvesting rights create defensible competitive advantages in the growing premium nutraceutical market.
Industry Context
Aker BioMarine ASA operates in Biotech/Nutraceuticals - Antarctic Krill Harvesting & Omega-3 Ingredients.
Key facts
Founded: 2006 · Headquarters: Lysaker, Norway · Employees: 249 · Revenue: $207M · Market cap: $8.66B NOK (~$730M USD)